Benzinga's Top Downgrades
December 03, 2013 at 08:47 AM EST
Analysts at Goldman Sachs downgraded Xcel Energy (NYSE: XEL ) from “buy” to “neutral.” The target price for Xcel Energy has been lowered from $31 to $28. Xcel Energy's shares closed at $27.92 yesterday. Sterne Agee downgraded Albany Molecular Research (NASDAQ: AMRI ) from “buy” to “neutral.” The target
